DiviDrip · PPH

PPH — VanEck Pharmaceutical ETF

PPH is VanEck's VanEck Pharmaceutical ETF (Healthcare). Trading at $104.99. Current dividend yield: 2.12%.

Dividend snapshot

Annual dividend rate$2.15
Current yield2.12%
Payment frequencyQuarterly
Next ex-dividend dateJul 01, 2026
Most recent payment dateApr 07, 2026
Last payment amount$0.8441
5-year dividend CAGR10.71%
3-year dividend CAGR15.13%
Expense ratio0.36%
Payout ratio0%
Market cap$966M
ExchangeNGM

Recent dividend payments

DateAmount / share
2026-04-01$0.8440
2025-12-29$0.3110
2025-10-01$0.3930
2025-07-01$0.6070
2025-04-01$0.5250
2024-12-27$0.4110
2024-10-01$0.4090
2024-07-01$0.3560

About PPH

The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.

Track PPH in DiviDrip

Add PPH to your portfolio on DiviDrip to track every buy, DRIP reinvestment, and dividend payment in one place. Free, no credit card, no upsell — built by dividend investors, for dividend investors.

Data refreshed 2026-05-23. Not investment advice. Yields and prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow

Made with Emergent